A novel pH-enzyme-dependent mesalamine colon-specific delivery system

Drug Des Devel Ther. 2016 Jun 20:10:2021-8. doi: 10.2147/DDDT.S107283. eCollection 2016.

Abstract

The aim of the present study was to design a new pH-enzyme double-dependent mesalamine colon-specific delivery system. The drug release behaviors in vitro and pharmacokinetics and biodistribution in vivo were further evaluated. The mean particle diameters of mesalamine-coated microparticles were 312.2 µm. In vitro, a small amount of mesalamine was released in HCl at a pH of 1.2 and PBS medium at a pH of 7.4 for 5 hours, and 71% of the entrapped mesalamine was further released during the subsequent 20 hours of incubation. A greater area under the plasma concentration-time curve (AUC)0-t was obtained for the coated microparticles (1.9-fold) compared to the suspensions group, which indicated that the encapsulated mesalamine had mostly been absorbed in rats over the period of 12 hours. The AUC0-t of the coated microparticles in colon was 2.63-fold higher compared to the suspensions (P<0.05). Hence, mesalamine-coated microparticles are considered to maintain the drug concentration within target ranges for a long period of time.

Keywords: biodistribution; colon specific; mesalamine; pH-enzyme; pharmacokinetics.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics*
  • Colon / metabolism*
  • Drug Delivery Systems / methods*
  • Drug Liberation
  • Female
  • Hydrogen-Ion Concentration
  • Male
  • Mesalamine / administration & dosage*
  • Mesalamine / pharmacokinetics*
  • Mice
  • Particle Size
  • Rats
  • Rats, Sprague-Dawley
  • Surface Properties
  • Tissue Distribution

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Mesalamine